Joel Greenblatt - Gotham Asset Management
Holding/activity history for Glaxosmithkline Plc (AP47)
← All AP47 superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q4 | 4,541 | <0.01 | Buy | <0.01 | $44.04 | $200,000 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q2 | 8,549 | 0.01 | $39.77 | $340,000 | SEC | ||
| 2021 Q1 | 8,549 | 0.01 | Buy | 0.01 | $35.68 | $305,000 | SEC |
| 2020 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2019 Q4 | 8,411 | <0.01 | $46.96 | $395,000 | SEC | ||
| 2019 Q3 | 8,411 | <0.01 | Add 0.37% | $42.68 | $359,000 | SEC | |
| 2019 Q2 | 8,380 | <0.01 | $39.98 | $335,000 | SEC | ||
| 2019 Q1 | 8,380 | <0.01 | Add 0.42% | $41.77 | $350,000 | SEC | |
| 2018 Q4 | 8,345 | <0.01 | Add 0.87% | $38.23 | $319,000 | SEC | |
| 2018 Q3 | 8,273 | <0.01 | $40.13 | $332,000 | SEC | ||
| 2018 Q2 | 8,273 | <0.01 | Reduce 70.36% | 0.01 | $40.25 | $333,000 | SEC |
| 2018 Q1 | 27,916 | 0.02 | Reduce 0.00% | $39.08 | $1,091,000 | SEC | |
| 2017 Q4 | 27,917 | 0.01 | Add 2.66% | <0.01 | $35.46 | $990,000 | SEC |
| 2017 Q3 | 27,193 | 0.02 | Add 2.63% | <0.01 | $40.60 | $1,104,000 | SEC |
| 2017 Q2 | 26,495 | 0.02 | Add 4.34% | <0.01 | $43.10 | $1,142,000 | SEC |
| 2017 Q1 | 25,392 | 0.01 | Reduce 3.51% | <0.01 | $42.18 | $1,071,000 | SEC |
| 2016 Q4 | 26,315 | 0.01 | Add 4.08% | <0.01 | $38.50 | $1,013,000 | SEC |
| 2016 Q3 | 25,284 | 0.01 | Reduce 2.22% | <0.01 | $43.11 | $1,090,000 | SEC |
| 2016 Q2 | 25,857 | 0.01 | Reduce 49.63% | 0.01 | $43.35 | $1,121,000 | SEC |
| 2016 Q1 | 51,331 | 0.02 | Reduce 1.24% | <0.01 | $40.54 | $2,081,000 | SEC |
| 2015 Q4 | 51,973 | 0.02 | Add 1.01% | <0.01 | $40.35 | $2,097,000 | SEC |
| 2015 Q3 | 51,451 | 0.02 | Reduce 35.81% | 0.01 | $38.44 | $1,978,000 | SEC |
| 2015 Q2 | 80,157 | 0.03 | Reduce 4.09% | <0.01 | $41.66 | $3,339,000 | SEC |
| 2015 Q1 | 83,578 | 0.03 | Add 0.41% | <0.01 | $46.15 | $3,857,000 | SEC |
| 2014 Q4 | 83,233 | 0.03 | Reduce 0.27% | <0.01 | $42.74 | $3,557,000 | SEC |
| 2014 Q3 | 83,462 | 0.04 | Reduce 0.08% | $45.97 | $3,837,000 | SEC | |
| 2014 Q2 | 83,528 | 0.06 | Add 0.09% | <0.01 | $53.48 | $4,467,000 | SEC |
| 2014 Q1 | 83,452 | 0.07 | $53.43 | $4,459,000 | SEC | ||
| 2013 Q4 | 83,452 | 0.11 | Buy | 0.11 | $53.40 | $4,456,000 | SEC |
| 2013 Q2 | 0 | 0.00 | Sell 100.00% | 0.17 | SEC | ||
| 2013 Q1 | 67,332 | 0.17 | Add 10.89% | 0.02 | $46.92 | $3,159,000 | SEC |
| 2012 Q4 | 60,720 | 0.16 | Reduce 32.53% | 0.10 | $43.46 | $2,639,000 | SEC |
| 2012 Q3 | 89,990 | 0.30 | Buy | 0.30 | $46.24 | $4,161,000 | SEC |
| 2011 Q1 | 0 | 0.00 | Sell 100.00% | 0.72 | SEC | ||
| 2010 Q4 | 50,826 | 0.72 | $39.21 | $1,993,000 | SEC |